Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15314806 | 0.90 | — | — | |
| SCHEMBL13012147 | 0.89 | — | — | |
| SCHEMBL24201802 | 0.82 | — | — | |
| SCHEMBL13671281 | 0.82 | — | — | |
| SCHEMBL566248 | 0.80 | TSHR (0.31) | — | |
| SCHEMBL12767708 | 0.79 | HSD17B10 (0.31) | — | |
| SCHEMBL7572703 | 0.78 | LMNA (0.30) | LMNA | |
| SCHEMBL13136018 | 0.78 | LMNA (0.30) | LMNA | |
| SCHEMBL25408699 | 0.77 | — | — | |
| SCHEMBL20019832 | 0.76 | ALDH1A1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115772192-A | Preparation method of fosfomycin trometamol EP impurity C | 深圳鼎邦化学品有限公司 | 2023-03-10 | — | — | CN | claimed |
| EP-2069339-B1 | SUBSTITUTED PIPERIDINOPHENYL OXAZOLIDINONES | WOCKHARDT RESEARCH CENTER (IN) | 2011-05-18 | — | — | EP | claimed |
| US-20100120721-A1 | SUBSTITUTED PIPERIDINOPHENYL OXAZOLIDINONES | WOCKHARDT RESEARCH CENTRE (IN) | 2010-05-13 | — | — | US | claimed |
| EP-2069339-A2 | SUBSTITUTED PIPERIDINOPHENYL OXAZOLIDINONES | Wockhardt Research Centre (IN) | 2009-06-17 | — | — | EP | claimed |
| WO-2008038092-A2 | SUBSTITUTED PIPERIDINOPHENYL OXAZOLIDINONES | WOCKHARDT RESEARCH CENTRE (IN) | 2008-04-03 | — | — | WO | claimed |
| CN-119490394-A | Isobutene hydroformylation catalytic system and method for catalytic synthesis of isovaleraldehyde | 宁夏天新药业有限公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-115772192-A | Preparation method of fosfomycin trometamol EP impurity C | 深圳鼎邦化学品有限公司 | 2023-03-10 | — | — | CN | disclosed |
| US-20200033361-A1 | Detection and Quantitation Method for Proteomics of Post-Translational Modifications | SICHUAN UNIVERSITY (CN) | 2020-01-30 | — | — | US | disclosed |
| CN-108627647-A | A kind of detection of posttranslational modification proteomics and quantitative approach | 四川大学 | 2018-10-09 | — | — | CN | disclosed |
| CN-101821277-B | Tetrahydropyran nucleic acid analogs | ISIS PHARMACEUTICALS INC | 2014-05-07 | — | — | CN | disclosed |
| EP-2647644-A1 | 2'-O-MODIFIED RNA | Chiralgen, Ltd. (JP) | 2013-10-09 | — | — | EP | disclosed |
| CN-103180463-A | A conjugate between a thiophilic solid phase and an oligonucleotide comprising a thiooxonucleotide | ROCHE DIAGNOSTICS GMBH | 2013-06-26 | — | — | CN | disclosed |
| US-20050043386-A1 | Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these | SANKYO COMPANY, LIMITED (JP) | 2005-02-24 | — | — | US | disclosed |
| EP-1471054-A1 | AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE | Sankyo Company, Limited (JP) | 2004-10-27 | — | — | EP | disclosed |
| US-20030144499-A1 | Photocleavable protecting groups and methods for their use | AFFYMETRIX, INC. (US) | 2003-07-31 | — | — | US | disclosed |
| US-6566515-B1 | Performing photochemical reactions on a surface; prepare chemical mixture, apply to surface, irradiate, monitor generation of reaction product | AFFYMETRIX, INC. | 2003-05-20 | — | — | US | disclosed |
| US-6147205-A | ARYLALKYLOXYCARBONYL GROUPS; FOR SOLID PHASE SYNTHESIS OF OLIGONUCLEOTIDES AND POLYPEPTIDES | AFFYMETRIX, INC. (US) | 2000-11-14 | — | — | US | disclosed |
| WO-1998039348-A9 | PHOTOCLEAVABLE PROTECTING GROUPS AND METHODS FOR THEIR USE | — | 1999-02-18 | — | — | WO | disclosed |
| WO-1998039348-A1 | PHOTOCLEAVABLE PROTECTING GROUPS AND METHODS FOR THEIR USE | AFFYMETRIX, INC. (US) | 1998-09-11 | — | — | WO | disclosed |
| US-4228109-A | HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1980-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043386-A1 | Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these | PHOSPHO1, CD4, FCGRT | LMNA 4143/4885 |
| US-20100120721-A1 | SUBSTITUTED PIPERIDINOPHENYL OXAZOLIDINONES | CYP2C19, ALPI, CYP3A7 | LMNA 4092/4885 |
| US-20030144499-A1 | Photocleavable protecting groups and methods for their use | RTCB, RRS1, GAR1 | LMNA 391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.